Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zelluna ASA's book value per share for the quarter that ended in Mar. 2026 was kr2.55.
During the past 12 months, Zelluna ASA's average Book Value Per Share Growth Rate was -51.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -55.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -42.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Zelluna ASA was 80.30% per year. The lowest was -55.60% per year. And the median was -6.50% per year.
Zelluna ASA's current price is kr21.95. Its book value per share for the quarter that ended in Mar. 2026 was kr2.55. Hence, today's PB Ratio of Zelluna ASA is 8.60.
During the past 11 years, the highest P/B Ratio of Zelluna ASA was 7.60. The lowest was 0.00. And the median was 0.00.
Zelluna ASA (OSTO:ULTIo) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Zelluna ASA Book Value per Share Related Terms
Zelluna ASA Book Value per Share Historical Data
* Premium members only.
The historical data trend for Zelluna ASA's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ULTIO vs VRTX, REGN, ALNY: Book Value per Share Comparison
For the Biotechnology subindustry, Zelluna ASA's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zelluna ASA PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zelluna ASA's PB Ratio distribution charts can be found below:
* The bar in red indicates where Zelluna ASA's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zelluna ASA (OSTO:ULTIO) has a Book Value per Share of kr2.55 as of Mar. 2026. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Zelluna ASA and its competitors.
Is Zelluna ASA's Book Value per Share too high?
Zelluna ASA's current Book Value per Share is kr2.55. Overall, Zelluna ASA has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Zelluna ASA's Book Value per Share compare to VRTX and REGN?
Zelluna ASA's Book Value per Share of kr2.55 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Biotechnology company?
A good Book Value per Share depends on the Biotechnology industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Zelluna ASA and its competitors. Zelluna ASA's current Book Value per Share is kr2.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zelluna ASA stock overvalued right now?
Zelluna ASA (OSTO:ULTIO) has a current Book Value per Share of kr2.55. The current Book Value per Share is kr2.55. Zelluna ASA's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Zelluna ASA (OSTO:ULTIO), the current Book Value per Share is kr2.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zelluna ASA is a biotechnology company established to eliminate solid cancers by unleashing the powerful elements of the immune system through pioneering the development of T cell receptor (TCR) guided natural killer (NK) cell therapies (TCR-NK). Its TCR-NK products are composed of healthy donor-derived NK cells that are genetically engineered to express a tumour-specific TCR that enable the TCR-NK cells to identify and eliminate cancer cells in the body of the patient. Its programme ZI-MA4-1, the first MAGE-A4-targeting TCR-NK therapy for solid tumours with high unmet medical need. Its other programmes include ZI-KL1-1, and ZI-PR-1.
28GF Score
Get the complete analysis for OSTO:ULTIO
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ULTIO has been successfully added to your 
